Literature DB >> 18369147

The flavivirus precursor membrane-envelope protein complex: structure and maturation.

Long Li1, Shee-Mei Lok, I-Mei Yu, Ying Zhang, Richard J Kuhn, Jue Chen, Michael G Rossmann.   

Abstract

Many viruses go through a maturation step in the final stages of assembly before being transmitted to another host. The maturation process of flaviviruses is directed by the proteolytic cleavage of the precursor membrane protein (prM), turning inert virus into infectious particles. We have determined the 2.2 angstrom resolution crystal structure of a recombinant protein in which the dengue virus prM is linked to the envelope glycoprotein E. The structure represents the prM-E heterodimer and fits well into the cryo-electron microscopy density of immature virus at neutral pH. The pr peptide beta-barrel structure covers the fusion loop in E, preventing fusion with host cell membranes. The structure provides a basis for identifying the stages of its pH-directed conformational metamorphosis during maturation, ending with release of pr when budding from the host.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18369147     DOI: 10.1126/science.1153263

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  224 in total

Review 1.  Virus maturation.

Authors:  David Veesler; John E Johnson
Journal:  Annu Rev Biophys       Date:  2012-02-23       Impact factor: 12.981

2.  Positive selection sites in the surface genes of dengue virus: phylogenetic analysis of the interserotypic branches of the four serotypes.

Authors:  Patsarin Rodpothong; Prasert Auewarakul
Journal:  Virus Genes       Date:  2012-01-06       Impact factor: 2.332

3.  Class II ADP-ribosylation factors are required for efficient secretion of dengue viruses.

Authors:  Mateusz Kudelko; Jean-Baptiste Brault; Kevin Kwok; Ming Yuan Li; Nathalie Pardigon; J S Malik Peiris; Roberto Bruzzone; Philippe Desprès; Béatrice Nal; Pei Gang Wang
Journal:  J Biol Chem       Date:  2011-11-21       Impact factor: 5.157

4.  Influence of pr-M cleavage on the heterogeneity of extracellular dengue virus particles.

Authors:  Jiraphan Junjhon; Thomas J Edwards; Utaiwan Utaipat; Valorie D Bowman; Heather A Holdaway; Wei Zhang; Poonsook Keelapang; Chunya Puttikhunt; Rushika Perera; Paul R Chipman; Watchara Kasinrerk; Prida Malasit; Richard J Kuhn; Nopporn Sittisombut
Journal:  J Virol       Date:  2010-06-02       Impact factor: 5.103

Review 5.  Feasibility of cross-protective vaccination against flaviviruses of the Japanese encephalitis serocomplex.

Authors:  Mario Lobigs; Michael S Diamond
Journal:  Expert Rev Vaccines       Date:  2012-02       Impact factor: 5.217

6.  In vitro reconstitution reveals key intermediate states of trimer formation by the dengue virus membrane fusion protein.

Authors:  Maofu Liao; Claudia Sánchez-San Martín; Aihua Zheng; Margaret Kielian
Journal:  J Virol       Date:  2010-03-24       Impact factor: 5.103

7.  The stem region of premembrane protein plays an important role in the virus surface protein rearrangement during dengue maturation.

Authors:  Qian Zhang; Cornelia Hunke; Yin Hoe Yau; Vernon Seow; Sumarlin Lee; Lukas Bahati Tanner; Xue Li Guan; Markus R Wenk; Guntur Fibriansah; Pau Ling Chew; Petra Kukkaro; Goran Biukovic; Pei-Yong Shi; Susana Geifman Shochat; Gerhard Grüber; Shee-Mei Lok
Journal:  J Biol Chem       Date:  2012-10-03       Impact factor: 5.157

8.  Structural basis of a potent human monoclonal antibody against Zika virus targeting a quaternary epitope.

Authors:  Feng Long; Michael Doyle; Estefania Fernandez; Andrew S Miller; Thomas Klose; Madhumati Sevvana; Aubrey Bryan; Edgar Davidson; Benjamin J Doranz; Richard J Kuhn; Michael S Diamond; James E Crowe; Michael G Rossmann
Journal:  Proc Natl Acad Sci U S A       Date:  2019-01-14       Impact factor: 11.205

Review 9.  Zika Virus: Immunity and Vaccine Development.

Authors:  Theodore C Pierson; Barney S Graham
Journal:  Cell       Date:  2016-09-29       Impact factor: 41.582

10.  A recombinant West Nile virus envelope protein vaccine candidate produced in Spodoptera frugiperda expresSF+ cells.

Authors:  Nathalie Bonafé; Joseph A Rininger; Richard G Chubet; Harald G Foellmer; Stacey Fader; John F Anderson; Sandra L Bushmich; Karen Anthony; Michel Ledizet; Erol Fikrig; Raymond A Koski; Paul Kaplan
Journal:  Vaccine       Date:  2008-11-07       Impact factor: 3.641

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.